Onderneming PharmaCyte Biotech, Inc. Other OTC
Aandelen
PMCB
US71715X1046
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15-08-22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01-01-15 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10-08-20 |
Lilli Brandtner
PRN | Corporate Officer/Principal | - | 10-02-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14-11-22 |
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15-08-22 |
Wayne Walker
BRD | Director/Board Member | 65 | 28-12-22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01-01-15 |
Director/Board Member | 50 | 15-08-22 | |
Director/Board Member | 65 | 10-07-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 21 604 315 | 7 767 289 ( 35,95 %) | 13 150 919 ( 60,87 %) | 35,95 % |
Aandeel B | 0 | 35 000 | 0 | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
FEMASYS INC. -.--% | 0 | -.--% | 0 $ |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. |